Bridgebio Pharma Inc
(BBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 366,967 | 540,919 | 757,049 | 363,773 | 413,973 |
| Marketable Securities | 343,714 | 300,020 | 148,126 | 182,220 | 122,080 |
| Receivables | 8,000 | N/A | N/A | 2,845 | N/A |
| TOTAL | $745,384 | $861,935 | $924,957 | $568,622 | $558,155 |
| Non-Current Assets | |||||
| PPE Net | 16,182 | 15,573 | 15,755 | 5,625 | 2,984 |
| Investments And Advances | 0 | 0 | 23,210 | 31,144 | 76,793 |
| Other Non-Current Assets | 26,127 | 27,719 | 25,877 | 26,288 | 2,598 |
| TOTAL | $42,309 | $43,292 | $64,842 | $63,057 | $82,375 |
| Total Assets | $787,693 | $905,227 | $989,799 | $631,679 | $640,530 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,839 | 12,835 | 13,086 | 8,852 | 10,270 |
| Accrued Expenses | 48,362 | 59,440 | 38,314 | 36,435 | 20,778 |
| Other current liabilities | 5,198 | 5,276 | 3,539 | 4,078 | 4,021 |
| TOTAL | $75,707 | $92,640 | $64,914 | $60,385 | $39,858 |
| Non-Current Liabilities | |||||
| Long Term Debt | 471,894 | 466,559 | 461,339 | 91,791 | 75,017 |
| Other Non-Current Liabilities | 38,587 | 35,602 | 26,760 | 16,463 | 4,642 |
| TOTAL | $496,173 | $486,981 | $475,867 | $97,561 | $78,975 |
| Total Liabilities | $571,880 | $579,621 | $540,781 | $157,946 | $118,833 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 122,568 | 122,362 | 121,370 | 123,766 | 123,575 |
| Common Shares | 125 | 125 | 124 | 124 | 117 |
| Retained earnings | -768,774 | -652,915 | -531,881 | -440,031 | -366,573 |
| Other shareholders' equity | 52,518 | 60,705 | 69,029 | 65,533 | 62,091 |
| TOTAL | $215,813 | $325,606 | $449,018 | $473,733 | $521,697 |
| Total Liabilities And Equity | $787,693 | $905,227 | $989,799 | $631,679 | $640,530 |